Process View
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbohydrate stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to carbohydrate stimulus"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NCF1 | neutrophil cytosolic factor 1 | 0.233 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.224 | ||
| AXL | AXL receptor tyrosine kinase | 0.200 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.186 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.163 | ||
| CCNY | cyclin Y | 0.139 | ||
| SNAP25 | synaptosomal-associated protein, 25kDa | 0.132 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.119 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.118 | Rat | |
| PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme | 0.086 | ||
| CRHR1 | corticotropin releasing hormone receptor 1 | 0.082 | Human | |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.081 | Rat | |
| IL1B | interleukin 1, beta | 0.075 | Rat | |
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.071 | ||
| CRH | corticotropin releasing hormone | 0.067 | Rat | |
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.057 | ||
| VAMP3 | vesicle-associated membrane protein 3 (cellubrevin) | 0.054 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.053 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.051 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.050 | ||
| PLAU | plasminogen activator, urokinase | 0.049 | Rat | |
| ARRB2 | arrestin, beta 2 | 0.048 | ||
| NAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha | 0.046 | ||
| HDAC1 | histone deacetylase 1 | 0.045 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.042 | ||
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.042 | ||
| RANBP9 | RAN binding protein 9 | 0.041 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.040 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.037 | ||
| CCT8 | chaperonin containing TCP1, subunit 8 (theta) | 0.037 | ||
| MPDZ | multiple PDZ domain protein | 0.037 | ||
| PRKCA | protein kinase C, alpha | 0.036 | Mouse | |
| SMAD2 | SMAD family member 2 | 0.036 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.035 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.032 | ||
| HDAC3 | histone deacetylase 3 | 0.030 | ||
| SMAD3 | SMAD family member 3 | 0.029 | ||
| AKAP11 | A kinase (PRKA) anchor protein 11 | 0.029 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.029 | ||
| NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 0.028 | Rat | |
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.027 | ||
| INCENP | inner centromere protein antigens 135/155kDa | 0.027 | ||
| IRF2 | interferon regulatory factor 2 | 0.025 | ||
| PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0.025 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.025 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.025 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.025 | ||
| S100B | S100 calcium binding protein B | 0.024 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.022 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.022 | ||
| ATF2 | activating transcription factor 2 | 0.022 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.022 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.021 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.020 | ||
| RNASE4 | ribonuclease, RNase A family, 4 | 0.020 | ||
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.019 | ||
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 0.019 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.019 | ||
| PLAT | plasminogen activator, tissue | 0.019 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.019 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.018 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.018 | ||
| NME1 | non-metastatic cells 1, protein (NM23A) expressed in | 0.018 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.016 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.016 | ||
| GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 0.016 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.016 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.015 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.015 | ||
| RYR2 | ryanodine receptor 2 (cardiac) | 0.015 | ||
| MYO16 | myosin XVI | 0.014 | ||
| PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.014 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.014 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.013 | ||
| HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 0.013 | Human | |
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.013 | ||
| CCND3 | cyclin D3 | 0.013 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.013 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.013 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.012 | ||
| AKIP1 | A kinase (PRKA) interacting protein 1 | 0.012 | ||
| IL8 | interleukin 8 | 0.012 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.012 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.012 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.011 | ||
| ARRDC3 | arrestin domain containing 3 | 0.011 | ||
| TBX5 | T-box 5 | 0.011 | ||
| MYOD1 | myogenic differentiation 1 | 0.011 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.011 | ||
| PRKAR2B | protein kinase, cAMP-dependent, regulatory, type II, beta | 0.011 | ||
| GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O | 0.011 | ||
| DLGAP2 | discs, large (Drosophila) homolog-associated protein 2 | 0.011 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.010 | ||
| FBXW11 | F-box and WD repeat domain containing 11 | 0.010 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.010 | ||
| HMGA1 | high mobility group AT-hook 1 | 0.010 | ||
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0.010 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.010 |